CU’s ClinImmune Labs enters private cord-blood banking arena

As the global market around umbilical cord blood stem-cell treatments reaches well into the billions of dollars annually, the University of Colorado has taken a pioneering step of sorts by expanding its own cord-blood banking services into the private realm.

ClinImmune Labs, a company owned by CU and housed at the school’s Anschutz Medical Campus in Aurora, has served as a public cord blood bank…